<VariationArchive RecordType="classified" VariationID="29722" VariationName="NM_032638.5(GATA2):c.1065_1067del (p.Thr358del)" VariationType="Deletion" Accession="VCV000029722" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2013-04-04" MostRecentSubmission="2021-07-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38677" VariationID="29722">
      <GeneList>
        <Gene Symbol="GATA2" FullName="GATA binding protein 2" GeneID="2624" HGNC_ID="HGNC:4171" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="128479422" stop="128493201" display_start="128479422" display_stop="128493201" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="128198264" stop="128212029" display_start="128198264" display_stop="128212029" Strand="-" />
          </Location>
          <OMIM>137295</OMIM>
          <Haploinsufficiency last_evaluated="2015-06-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GATA2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-06-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GATA2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_032638.5(GATA2):c.1065_1067del (p.Thr358del)</Name>
      <CanonicalSPDI>NC_000003.12:128481894:GTTGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="128481895" stop="128481897" display_start="128481895" display_stop="128481897" variantLength="3" positionVCF="128481894" referenceAlleleVCF="GGTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="128200738" stop="128200740" display_start="128200738" display_stop="128200740" variantLength="3" positionVCF="128200737" referenceAlleleVCF="GGTT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>T344del</ProteinChange>
      <ProteinChange>T358del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.128200740_128200742del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.128200740_128200742del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.128481897_128481899del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.128481897_128481899del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029334.1" sequenceAccession="NG_029334" sequenceVersion="1" change="g.16291_16293del">
            <Expression>NG_029334.1:g.16291_16293del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145661.2" sequenceAccession="NM_001145661" sequenceVersion="2" change="c.1065_1067del">
            <Expression>NM_001145661.2:c.1065_1067del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001139133.1" sequenceAccession="NP_001139133" sequenceVersion="1" change="p.Thr358del">
            <Expression>NP_001139133.1:p.Thr358del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145662.1" sequenceAccession="NM_001145662" sequenceVersion="1" change="c.1023_1025del">
            <Expression>NM_001145662.1:c.1023_1025del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001139134.1" sequenceAccession="NP_001139134" sequenceVersion="1" change="p.Thr344del">
            <Expression>NP_001139134.1:p.Thr344del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032638.5" sequenceAccession="NM_032638" sequenceVersion="5" change="c.1065_1067del" MANESelect="true">
            <Expression>NM_032638.5:c.1065_1067del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116027.2" sequenceAccession="NP_116027" sequenceVersion="2" change="p.Thr358del">
            <Expression>NP_116027.2:p.Thr358del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032638.4" sequenceAccession="NM_032638" sequenceVersion="4" change="c.1065_1067delAAC">
            <Expression>NM_032638.4:c.1065_1067delAAC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_295" sequenceAccession="LRG_295">
            <Expression>LRG_295:g.16291_16293del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="137295.0014" DB="OMIM" />
        <XRef Type="rs" ID="1576745225" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032638.5(GATA2):c.1065_1067del (p.Thr358del) AND Myelodysplastic syndrome" Accession="RCV000022574" Version="2">
        <ClassifiedConditionList TraitSetID="7624">
          <ClassifiedCondition DB="MedGen" ID="C3463824">Myelodysplastic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-09-04" SubmissionCount="1">risk factor</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_032638.5(GATA2):c.1065_1067del (p.Thr358del) AND multiple conditions" Accession="RCV001542228" Version="1">
        <ClassifiedConditionList TraitSetID="68813">
          <ClassifiedCondition DB="MedGen" ID="C3279664">Deafness-lymphedema-leukemia syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN300066">GATA2 deficiency with susceptibility to MDS/AML</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2021-07-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21892162</ID>
        </Citation>
        <DescriptionHistory Dated="2021-07-24">
          <Description>risk factor</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7624" Type="Disease">
            <Trait ID="16591" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myelodysplastic syndromes</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myelodysplastic syndrome</ElementValue>
                <XRef ID="Myelodysplastic+syndromes/5021" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018881" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
                <XRef Type="Allelic variant" ID="137295.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="137295.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myelodysplastic syndrome, somatic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDS</ElementValue>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7132" />
                <XRef ID="7132" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic stem cell disorders characterized by ineffective hematopoiesis resulting in low blood counts, most commonly anemia, and a risk of progression to acute myeloid leukemia (AML; 601626). Blood smears and bone marrow biopsies show dysplastic changes in myeloid cells, with abnormal proliferation and differentiation of 1 or more lineages (erythroid, myeloid, megakaryocytic). MDS can be subdivided into several categories based on morphologic characteristics, such as low-grade refractory anemia (RA) or high-grade refractory anemia with excess blasts (RAEB). Bone marrow biopsies of some patients show ringed sideroblasts (RARS), which reflects abnormal iron staining in mitochondria surrounding the nucleus of erythrocyte progenitors (summary by Delhommeau et al., 2009 and Papaemmanuil et al., 2011).</Attribute>
                <XRef Type="MIM" ID="614286" DB="OMIM" />
              </AttributeSet>
              <XRef ID="52688" DB="Orphanet" />
              <XRef ID="C3463824" DB="MedGen" />
              <XRef ID="D009190" DB="MeSH" />
              <XRef ID="MONDO:0018881" DB="MONDO" />
              <XRef Type="MIM" ID="614286" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="68813" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16072" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lymphedema, primary, with myelodysplasia</ElementValue>
                <XRef ID="Lymphedema%2C+primary%2C+with+myelodysplasia/8771" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deafness-lymphedema-leukemia syndrome</ElementValue>
                <XRef ID="MONDO:0013540" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Emberger syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13030" />
                <XRef ID="13030" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3226" DB="Orphanet" />
              <XRef ID="C3279664" DB="MedGen" />
              <XRef ID="MONDO:0013540" DB="MONDO" />
              <XRef Type="MIM" ID="614038" DB="OMIM" />
            </Trait>
            <Trait ID="50158" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GATA2 deficiency with susceptibility to MDS/AML</ElementValue>
                <XRef ID="MONDO:0042982" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13373" />
                <XRef ID="13373" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="CN300066" DB="MedGen" />
              <XRef ID="MONDO:0042982" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49119" SubmissionDate="2013-01-08" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="137295.0014_MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO" title="GATA2, 3-BP DEL, 1063ACA_MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO" />
        <ClinVarAccession Accession="SCV000043863" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-09-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>risk factor</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a father and son with myelodysplastic syndrome (MDS; 614286), Hahn et al. (2011) identified heterozygosity for a 3-bp deletion (1063delACA) in the GATA2 gene, resulting in deletion of a highly conserved threonine residue at position 355 (thr355del) in the zinc finger-2 (ZF2) domain. The mutation was not found in 695 nonleukemic ethnically matched controls. Luciferase reporter assay experiments demonstrated that the mutation dramatically reduced induction of known GATA2-responsive enhancers compared to wildtype, with a dominant-negative effect. Microarray analysis revealed that thr355del is an almost total loss-of-function mutant, and studies using HL60 promyelocytes showed differential effects on cellular differentiation and apoptosis compared to wildtype.</Attribute>
              <Citation>
                <ID Source="PubMed">21892162</ID>
              </Citation>
              <XRef DB="OMIM" ID="614286" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GATA2" />
          </GeneList>
          <Name>GATA2, 3-BP DEL, 1063ACA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1063ACA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="137295.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3458333" SubmissionDate="2021-07-12" DateLastUpdated="2021-07-24" DateCreated="2021-07-24">
        <ClinVarSubmissionID localKey="NM_032638.5:c.1065_1067del|MONDO:42982;0013540" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001760896" DateUpdated="2021-07-24" DateCreated="2021-07-24" Type="SCV" Version="1" SubmitterName="Molecular Pathology Research Laboratory, SA Pathology" OrgID="507864" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21892162</ID>
          </Citation>
          <Comment>PS3, PS4_Moderate, PM2, PM4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Myelodysplasia</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Acute Myeloid Leukemia</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GATA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032638.5:c.1065_1067del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0042982" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0013540" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9991765</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49119" TraitType="Disease" MappingType="Name" MappingValue="MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO" MappingRef="Preferred">
        <MedGen CUI="C3463824" Name="Myelodysplastic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3458333" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0013540" MappingRef="MONDO">
        <MedGen CUI="C3279664" Name="Deafness-lymphedema-leukemia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3458333" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0042982" MappingRef="MONDO">
        <MedGen CUI="CN300066" Name="GATA2 deficiency with susceptibility to MDS/AML" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3458333" TraitType="Finding" MappingType="Name" MappingValue="Acute Myeloid Leukemia" MappingRef="Preferred">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3458333" TraitType="Finding" MappingType="Name" MappingValue="Myelodysplasia" MappingRef="Preferred">
        <MedGen CUI="C0026985" Name="Myelodysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

